BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 24, 2024
See today's BioWorld Asia
Home
» Regulatory actions for Dec. 27-Jan. 2, 2023
To read the full story,
subscribe
or
sign in
.
Regulatory actions for Dec. 27-Jan. 2, 2023
Jan. 3, 2023
No Comments
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Antengene, Astrazeneca, Basilea, Beigene, Biogen, Calliditas, Coherus, Daiichi Sankyo, Eisai, Elpiscience, Everest Medicines, Immutep, Innocare, Junshi, Kaken, Kite, Leo, Mediwound, Merck, Mindrank AI, Neuren, Revive.
BioWorld Asia
Briefs
Regulatory actions